A prospective, multicenter, randomized study of anti-CCR4 monoclonal antibody mogamulizumab versus investigator's choice in the treatment of patients with relapsed/refractory adult T-cell leukemia-lymphoma: Overall response rate, progression-free survival, and overall survival Meeting Abstract
| Authors: | Phillips, A.; Fields, P.; Hermine, O.; Ramos, J. C.; Beltran, B. E.; Pereira, J.; Brites, C.; Wandroo, F. A.; Lill, M.; Feldman, T. A.; Casanova, L.; Janakiram, M.; Meniane, J. C.; Sawas, A.; Cook, L. B.; Kurman, M. R.; George, J.; Dwyer, K.; Leoni, M.; Conlon, K.; Taylor, G. P.; Gonsky, J.; Horwitz, S. M. |
| Abstract Title: | A prospective, multicenter, randomized study of anti-CCR4 monoclonal antibody mogamulizumab versus investigator's choice in the treatment of patients with relapsed/refractory adult T-cell leukemia-lymphoma: Overall response rate, progression-free survival, and overall survival |
| Meeting Title: | 58th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 128 |
| Issue: | 22 |
| Meeting Dates: | 2016 Dec 3-6 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2016-12-02 |
| Start Page: | 4159 |
| Language: | English |
| ACCESSION: | WOS:000394452308057 |
| DOI: | 10.1182/blood.V128.22.4159.4159 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 624 -- Source: Wos |
